Although Shh pathway overactivation is clearly linked to medulloblastoma, the etiopathology of SHH-MB is mainly related to the mutation of Hedgehog pathway components rather than the amplification of the SHH gene, which represents only 3% of SHH-MB [208]. The gene discussed is SHH; the disease is medulloblastoma.